RAGE Fusion Protein Compositions And Methods Of Use

RAGE Fusion Protein Compositions And Methods Of Use

Disclosed are fusion proteins comprising a RAGE polypeptide, wherein the RAGE polypeptide comprises a fragment of a mammalian wild type RAGE peptide and at least one point mutation in the RAGE polypeptide portion of the fusion protein relative to the wild type RAGE peptide. The point mutation may re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RAJADHYAKSHA MANOJ, WENTLAND JO-ANN, VIOLAND BERNARD N, ROTHLEIN ROBERT, WEBSTER JEFFREY C, BLECK GREGORY T, KATRAGADDA MADAN
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RAJADHYAKSHA MANOJ
WENTLAND JO-ANN
VIOLAND BERNARD N
ROTHLEIN ROBERT
WEBSTER JEFFREY C
BLECK GREGORY T
KATRAGADDA MADAN
description Disclosed are fusion proteins comprising a RAGE polypeptide, wherein the RAGE polypeptide comprises a fragment of a mammalian wild type RAGE peptide and at least one point mutation in the RAGE polypeptide portion of the fusion protein relative to the wild type RAGE peptide. The point mutation may remove and/or alter a glycosylation site or an enzyme cleavage site. Also disclosed are nucleic acids encoding such proteins as well as methods of using such proteins for treating RAGE-mediated pathologies.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2013142792A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2013142792A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2013142792A13</originalsourceid><addsrcrecordid>eNrjZDAOcnR3VXArLc7Mz1MIKMovSc3MU3DOzy3IL84sAYoVKzjmpSj4ppZk5KcUK_inKYQWp_IwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvjQYCMDQ2NDEyNzSyNHQ2PiVAEAI3IsMA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>RAGE Fusion Protein Compositions And Methods Of Use</title><source>esp@cenet</source><creator>RAJADHYAKSHA MANOJ ; WENTLAND JO-ANN ; VIOLAND BERNARD N ; ROTHLEIN ROBERT ; WEBSTER JEFFREY C ; BLECK GREGORY T ; KATRAGADDA MADAN</creator><creatorcontrib>RAJADHYAKSHA MANOJ ; WENTLAND JO-ANN ; VIOLAND BERNARD N ; ROTHLEIN ROBERT ; WEBSTER JEFFREY C ; BLECK GREGORY T ; KATRAGADDA MADAN</creatorcontrib><description>Disclosed are fusion proteins comprising a RAGE polypeptide, wherein the RAGE polypeptide comprises a fragment of a mammalian wild type RAGE peptide and at least one point mutation in the RAGE polypeptide portion of the fusion protein relative to the wild type RAGE peptide. The point mutation may remove and/or alter a glycosylation site or an enzyme cleavage site. Also disclosed are nucleic acids encoding such proteins as well as methods of using such proteins for treating RAGE-mediated pathologies.</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130606&amp;DB=EPODOC&amp;CC=US&amp;NR=2013142792A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130606&amp;DB=EPODOC&amp;CC=US&amp;NR=2013142792A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RAJADHYAKSHA MANOJ</creatorcontrib><creatorcontrib>WENTLAND JO-ANN</creatorcontrib><creatorcontrib>VIOLAND BERNARD N</creatorcontrib><creatorcontrib>ROTHLEIN ROBERT</creatorcontrib><creatorcontrib>WEBSTER JEFFREY C</creatorcontrib><creatorcontrib>BLECK GREGORY T</creatorcontrib><creatorcontrib>KATRAGADDA MADAN</creatorcontrib><title>RAGE Fusion Protein Compositions And Methods Of Use</title><description>Disclosed are fusion proteins comprising a RAGE polypeptide, wherein the RAGE polypeptide comprises a fragment of a mammalian wild type RAGE peptide and at least one point mutation in the RAGE polypeptide portion of the fusion protein relative to the wild type RAGE peptide. The point mutation may remove and/or alter a glycosylation site or an enzyme cleavage site. Also disclosed are nucleic acids encoding such proteins as well as methods of using such proteins for treating RAGE-mediated pathologies.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAOcnR3VXArLc7Mz1MIKMovSc3MU3DOzy3IL84sAYoVKzjmpSj4ppZk5KcUK_inKYQWp_IwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvjQYCMDQ2NDEyNzSyNHQ2PiVAEAI3IsMA</recordid><startdate>20130606</startdate><enddate>20130606</enddate><creator>RAJADHYAKSHA MANOJ</creator><creator>WENTLAND JO-ANN</creator><creator>VIOLAND BERNARD N</creator><creator>ROTHLEIN ROBERT</creator><creator>WEBSTER JEFFREY C</creator><creator>BLECK GREGORY T</creator><creator>KATRAGADDA MADAN</creator><scope>EVB</scope></search><sort><creationdate>20130606</creationdate><title>RAGE Fusion Protein Compositions And Methods Of Use</title><author>RAJADHYAKSHA MANOJ ; WENTLAND JO-ANN ; VIOLAND BERNARD N ; ROTHLEIN ROBERT ; WEBSTER JEFFREY C ; BLECK GREGORY T ; KATRAGADDA MADAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2013142792A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>RAJADHYAKSHA MANOJ</creatorcontrib><creatorcontrib>WENTLAND JO-ANN</creatorcontrib><creatorcontrib>VIOLAND BERNARD N</creatorcontrib><creatorcontrib>ROTHLEIN ROBERT</creatorcontrib><creatorcontrib>WEBSTER JEFFREY C</creatorcontrib><creatorcontrib>BLECK GREGORY T</creatorcontrib><creatorcontrib>KATRAGADDA MADAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RAJADHYAKSHA MANOJ</au><au>WENTLAND JO-ANN</au><au>VIOLAND BERNARD N</au><au>ROTHLEIN ROBERT</au><au>WEBSTER JEFFREY C</au><au>BLECK GREGORY T</au><au>KATRAGADDA MADAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>RAGE Fusion Protein Compositions And Methods Of Use</title><date>2013-06-06</date><risdate>2013</risdate><abstract>Disclosed are fusion proteins comprising a RAGE polypeptide, wherein the RAGE polypeptide comprises a fragment of a mammalian wild type RAGE peptide and at least one point mutation in the RAGE polypeptide portion of the fusion protein relative to the wild type RAGE peptide. The point mutation may remove and/or alter a glycosylation site or an enzyme cleavage site. Also disclosed are nucleic acids encoding such proteins as well as methods of using such proteins for treating RAGE-mediated pathologies.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2013142792A1
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title RAGE Fusion Protein Compositions And Methods Of Use
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T00%3A51%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RAJADHYAKSHA%20MANOJ&rft.date=2013-06-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2013142792A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true